Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 21.14 Billion USD | -2.2% |
| 2022 | 21.62 Billion USD | 4.44% |
| 2021 | 20.7 Billion USD | 2.92% |
| 2020 | 20.11 Billion USD | 13.18% |
| 2019 | 17.77 Billion USD | 2.89% |
| 2018 | 17.27 Billion USD | -20.53% |
| 2017 | 21.73 Billion USD | -16.81% |
| 2016 | 26.12 Billion USD | -8.75% |
| 2015 | 28.63 Billion USD | 35.69% |
| 2014 | 21.1 Billion USD | 152.92% |
| 2013 | 8.34 Billion USD | 15.38% |
| 2012 | 7.23 Billion USD | 15.5% |
| 2011 | 6.26 Billion USD | 2.98% |
| 2010 | 6.07 Billion USD | 12.26% |
| 2009 | 5.41 Billion USD | 28.69% |
| 2008 | 4.2 Billion USD | 21.59% |
| 2007 | 3.46 Billion USD | 33.49% |
| 2006 | 2.59 Billion USD | 46.65% |
| 2005 | 1.76 Billion USD | 52.68% |
| 2004 | 1.15 Billion USD | 53.35% |
| 2003 | 755.17 Million USD | 90.19% |
| 2002 | 397.06 Million USD | 108.98% |
| 2001 | 190 Million USD | 9.17% |
| 2000 | 174.05 Million USD | 14.43% |
| 1999 | 152.1 Million USD | 337.07% |
| 1998 | 34.8 Million USD | -16.75% |
| 1997 | 41.8 Million USD | 12.97% |
| 1996 | 37 Million USD | 527.12% |
| 1995 | 5.9 Million USD | -14.49% |
| 1994 | 6.9 Million USD | 0.0% |
| 1992 | 5.9 Million USD | 55.26% |
| 1991 | 3.8 Million USD | 80.95% |
| 1990 | 2.1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5.13 Billion USD | -7.58% |
| 2024 Q2 | 5.4 Billion USD | 5.28% |
| 2023 Q4 | 5.55 Billion USD | 1.28% |
| 2023 Q1 | 4.95 Billion USD | -17.39% |
| 2023 FY | 21.14 Billion USD | -2.2% |
| 2023 Q2 | 5.15 Billion USD | 4.16% |
| 2023 Q3 | 5.48 Billion USD | 6.36% |
| 2022 Q3 | 5.64 Billion USD | 17.21% |
| 2022 Q2 | 4.81 Billion USD | -6.74% |
| 2022 FY | 21.62 Billion USD | 4.44% |
| 2022 Q4 | 5.99 Billion USD | 6.13% |
| 2022 Q1 | 5.16 Billion USD | 11.89% |
| 2021 FY | 20.7 Billion USD | 2.92% |
| 2021 Q1 | 5.06 Billion USD | -15.96% |
| 2021 Q2 | 4.82 Billion USD | -4.64% |
| 2021 Q3 | 6.19 Billion USD | 28.4% |
| 2021 Q4 | 4.61 Billion USD | -25.51% |
| 2020 Q1 | 4.57 Billion USD | 9.13% |
| 2020 Q2 | 4.07 Billion USD | -10.92% |
| 2020 Q4 | 6.02 Billion USD | 10.8% |
| 2020 FY | 20.11 Billion USD | 13.18% |
| 2020 Q3 | 5.43 Billion USD | 33.27% |
| 2019 Q4 | 4.19 Billion USD | -8.16% |
| 2019 Q1 | 4.32 Billion USD | 2.34% |
| 2019 FY | 17.77 Billion USD | 2.89% |
| 2019 Q3 | 4.56 Billion USD | -2.48% |
| 2019 Q2 | 4.68 Billion USD | 8.35% |
| 2018 Q4 | 4.22 Billion USD | -6.32% |
| 2018 FY | 17.27 Billion USD | -20.53% |
| 2018 Q3 | 4.51 Billion USD | 1.3% |
| 2018 Q2 | 4.45 Billion USD | 8.93% |
| 2018 Q1 | 4.08 Billion USD | -12.91% |
| 2017 Q4 | 4.69 Billion USD | -14.36% |
| 2017 Q1 | 5.54 Billion USD | -11.16% |
| 2017 FY | 21.73 Billion USD | -16.81% |
| 2017 Q2 | 6.01 Billion USD | 8.42% |
| 2017 Q3 | 5.48 Billion USD | -8.89% |
| 2016 Q2 | 6.91 Billion USD | 4.71% |
| 2016 FY | 26.12 Billion USD | -8.75% |
| 2016 Q1 | 6.6 Billion USD | -11.32% |
| 2016 Q3 | 6.37 Billion USD | -7.83% |
| 2016 Q4 | 6.24 Billion USD | -1.98% |
| 2015 Q4 | 7.44 Billion USD | 2.95% |
| 2015 Q3 | 7.23 Billion USD | -0.21% |
| 2015 Q2 | 7.24 Billion USD | 7.96% |
| 2015 Q1 | 6.71 Billion USD | 7.37% |
| 2015 FY | 28.63 Billion USD | 35.69% |
| 2014 FY | 21.1 Billion USD | 152.92% |
| 2014 Q4 | 6.25 Billion USD | 23.67% |
| 2014 Q3 | 5.05 Billion USD | -9.91% |
| 2014 Q1 | 4.18 Billion USD | 85.02% |
| 2014 Q2 | 5.61 Billion USD | 34.03% |
| 2013 Q3 | 2.1 Billion USD | 0.88% |
| 2013 FY | 8.34 Billion USD | 15.38% |
| 2013 Q1 | 1.89 Billion USD | -0.8% |
| 2013 Q2 | 2.08 Billion USD | 9.78% |
| 2013 Q4 | 2.26 Billion USD | 7.68% |
| 2012 FY | 7.23 Billion USD | 15.5% |
| 2012 Q4 | 1.91 Billion USD | 4.54% |
| 2012 Q3 | 1.82 Billion USD | 2.32% |
| 2012 Q2 | 1.78 Billion USD | 5.07% |
| 2012 Q1 | 1.7 Billion USD | 5.3% |
| 2011 FY | 6.26 Billion USD | 2.98% |
| 2011 Q4 | 1.61 Billion USD | 1.65% |
| 2011 Q3 | 1.58 Billion USD | -0.86% |
| 2011 Q2 | 1.6 Billion USD | 10.43% |
| 2011 Q1 | 1.45 Billion USD | -3.35% |
| 2010 Q2 | 1.47 Billion USD | -10.56% |
| 2010 Q3 | 1.46 Billion USD | -0.79% |
| 2010 FY | 6.07 Billion USD | 12.26% |
| 2010 Q4 | 1.5 Billion USD | 2.9% |
| 2010 Q1 | 1.64 Billion USD | 5.54% |
| 2009 FY | 5.41 Billion USD | 28.69% |
| 2009 Q2 | 1.26 Billion USD | 5.25% |
| 2009 Q3 | 1.39 Billion USD | 10.09% |
| 2009 Q4 | 1.55 Billion USD | 12.02% |
| 2009 Q1 | 1.2 Billion USD | 8.53% |
| 2008 Q4 | 1.1 Billion USD | 3.32% |
| 2008 Q3 | 1.07 Billion USD | 5.79% |
| 2008 Q2 | 1.01 Billion USD | -0.58% |
| 2008 Q1 | 1.01 Billion USD | 15.82% |
| 2008 FY | 4.2 Billion USD | 21.59% |
| 2007 Q3 | 860.34 Million USD | -0.53% |
| 2007 Q4 | 879.18 Million USD | 2.19% |
| 2007 Q2 | 864.95 Million USD | 0.95% |
| 2007 Q1 | 856.79 Million USD | 15.17% |
| 2007 FY | 3.46 Billion USD | 33.49% |
| 2006 FY | 2.59 Billion USD | 46.65% |
| 2006 Q2 | 607.41 Million USD | 0.81% |
| 2006 Q1 | 602.52 Million USD | 12.6% |
| 2006 Q3 | 638.94 Million USD | 5.19% |
| 2006 Q4 | 743.93 Million USD | 16.43% |
| 2005 Q1 | 372.99 Million USD | 16.24% |
| 2005 FY | 1.76 Billion USD | 52.68% |
| 2005 Q4 | 535.12 Million USD | 25.04% |
| 2005 Q3 | 427.95 Million USD | -0.94% |
| 2005 Q2 | 432 Million USD | 15.82% |
| 2004 Q1 | 274.17 Million USD | 19.08% |
| 2004 Q3 | 285.34 Million USD | 2.78% |
| 2004 Q4 | 320.88 Million USD | 12.45% |
| 2004 Q2 | 277.63 Million USD | 1.26% |
| 2004 FY | 1.15 Billion USD | 53.35% |
| 2003 Q1 | 143.73 Million USD | 14.55% |
| 2003 Q4 | 230.24 Million USD | 31.99% |
| 2003 Q2 | 206.76 Million USD | 43.85% |
| 2003 Q3 | 174.43 Million USD | -15.64% |
| 2003 FY | 755.17 Million USD | 90.19% |
| 2002 Q4 | 125.47 Million USD | 10.48% |
| 2002 FY | 397.06 Million USD | 108.98% |
| 2002 Q2 | 91.64 Million USD | 38.07% |
| 2002 Q3 | 113.57 Million USD | 23.93% |
| 2002 Q1 | 66.37 Million USD | 8.54% |
| 2001 Q1 | 47.25 Million USD | -7.5% |
| 2001 Q3 | 41.7 Million USD | 4.56% |
| 2001 Q2 | 39.89 Million USD | -15.59% |
| 2001 FY | 190 Million USD | 9.17% |
| 2001 Q4 | 61.15 Million USD | 46.63% |
| 2000 Q1 | 40.16 Million USD | -8.92% |
| 2000 FY | 174.05 Million USD | 14.43% |
| 2000 Q2 | 44.37 Million USD | 10.48% |
| 2000 Q3 | 38.41 Million USD | -13.44% |
| 2000 Q4 | 51.08 Million USD | 32.99% |
| 1999 Q2 | 9.5 Million USD | 69.64% |
| 1999 Q3 | 38.9 Million USD | 309.47% |
| 1999 Q4 | 44.1 Million USD | 13.37% |
| 1999 FY | 152.1 Million USD | 337.07% |
| 1999 Q1 | 5.6 Million USD | -41.67% |
| 1998 Q3 | 3.6 Million USD | -52.63% |
| 1998 Q1 | 14.1 Million USD | 35.58% |
| 1998 Q2 | 7.6 Million USD | -46.1% |
| 1998 Q4 | 9.6 Million USD | 166.67% |
| 1998 FY | 34.8 Million USD | -16.75% |
| 1997 Q4 | 10.4 Million USD | 89.09% |
| 1997 Q2 | 20.1 Million USD | 246.55% |
| 1997 Q1 | 5.8 Million USD | -6.45% |
| 1997 FY | 41.8 Million USD | 12.97% |
| 1997 Q3 | 5.5 Million USD | -72.64% |
| 1996 Q3 | 25.1 Million USD | 543.59% |
| 1996 FY | 37 Million USD | 527.12% |
| 1996 Q4 | 6.2 Million USD | -75.3% |
| 1996 Q2 | 3.9 Million USD | 105.26% |
| 1996 Q1 | 1.9 Million USD | 0.0% |
| 1995 Q2 | 2 Million USD | 0.0% |
| 1995 Q3 | 2.2 Million USD | 10.0% |
| 1995 FY | 5.9 Million USD | -14.49% |
| 1995 Q1 | 2 Million USD | -51.22% |
| 1994 Q3 | -4.6 Million USD | -330.0% |
| 1994 Q4 | 4.1 Million USD | 189.13% |
| 1994 FY | 6.9 Million USD | 0.0% |
| 1994 Q1 | 1.9 Million USD | -5.0% |
| 1994 Q2 | 2 Million USD | 5.26% |
| 1993 Q4 | 2 Million USD | 25.0% |
| 1993 Q1 | 1.4 Million USD | -17.65% |
| 1993 Q2 | 1.5 Million USD | 7.14% |
| 1993 Q3 | 1.6 Million USD | 6.67% |
| 1992 FY | 5.9 Million USD | 55.26% |
| 1992 Q4 | 1.7 Million USD | 21.43% |
| 1992 Q3 | 1.4 Million USD | -6.67% |
| 1992 Q2 | 1.5 Million USD | -21.05% |
| 1992 Q1 | 1.9 Million USD | 280.0% |
| 1991 Q1 | 1.2 Million USD | 1100.0% |
| 1991 Q2 | 200 Thousand USD | -83.33% |
| 1991 Q3 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 500 Thousand USD | 150.0% |
| 1991 FY | 3.8 Million USD | 80.95% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q4 | 100 Thousand USD | 0.0% |
| 1990 FY | 2.1 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amgen Inc. | 19.73 Billion USD | -7.138% |
| AstraZeneca PLC | 37.54 Billion USD | 43.67% |
| Biogen Inc. | 7.3 Billion USD | -189.611% |
| MIRA Pharmaceuticals, Inc. | -8.52 Million USD | 248139.86% |
| Scilex Holding Company | 31.06 Million USD | -67983.188% |
| Scilex Holding Company | 31.06 Million USD | -67983.188% |